PEOPLE ON THE MOVE

Boehringer Ingelheim biopharma head joins Merck, plus EMA, Shire, EFPIA

(Picture credit: flickr/SalFalko)

Simon Sturge leaves Boehringer Ingelheim to head Merck's biosimilars unit, as well as the European Medicines Agency, Shire and EFPIA in this week's People on the Move column.

Related News

UCB switches CEOs ahead of product launches, and other big movers

UCB switches CEOs ahead of product launches, and other big movers

EMA wants to make risk management for new drugs more transparent

EMA wants to make risk management for new drugs more transparent

People on the Move: Pharma movers and shakers

People on the Move: Pharma movers and shakers

Canary Wharf, London home to the EMA

EMA to rejig variations procedures and industry contact staff in April

Boehringer aims to cut German costs 15% as H1 sales fall

Boehringer Ingelheim aims to cut German costs 15% as revenues drop

Have you got what it takes to be a big pharma CEO?

Have you got what it takes to be a big pharma CEO?

EMA and FDA to talk drug safety every month

EMA and FDA to start monthly transatlantic drug safety teleconferences

A tale of two Mercks: a timeline for confused protestors

A tale of two Mercks: a guide for confused protestors

People on the move: New hires and a hunt for a CEO

People on the move: New hires and a hunt for a CEO

Changes at the top for European Fine Chemicals Group and more

Changes at the top for European Fine Chemicals Group and more